HOME >> BIOLOGY >> NEWS
ASH presents advocacy awards to Sen. Dianne Feinstein and Claude Lenfant, M.D.

(San Diego, Calif., December 5, 2003) The American Society of Hematology (ASH) will honor two leaders and champions of health research with this year's Advocacy Awards.

ASH will present the 2003 Public Service Award to Sen. Dianne Feinstein (D-Calif.), and the first-ever Outstanding Lifetime Service Award to Claude Lenfant, M.D., former Director of the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI).

The Society applauds Sen. Feinstein for her leadership in the Senate on medical research and patient care related issues and is pleased to honor her achievements with the 2003 ASH Award for Public Service. Established in 1997, this Award is presented annually by the Society to an elected U.S. public official who has demonstrated effective leadership on issues of importance to hematology research and practice.

Sen. Feinstein has represented California in the Senate since 1992, and serves as the co-chair of the Senate Cancer Coalition as well as vice-chair of the National Dialogue on Cancer. In her 10 years of service in the Senate, she has dedicated herself to fighting cancer by improving research, creating incentives for effective treatments, and improving the quality of care that patients receive. Earlier this year, Sen. Feinstein reintroduced her legislation, the National Cancer Act of 2003, which provides a comprehensive federal effort related to the prevention, early detection, and treatment of cancer.

Dr. Lenfant is the recipient of ASH's first Outstanding Lifetime Service Award. This new award recognizes an individual who has displayed effective leadership in areas relevant to the mission of the Society throughout a lifetime.

Dr. Lenfant, the recipient of the 1999 ASH Award for Outstanding Service, has served as Director of the National Heart, Lung, and Blood Institute for more than 21 years. During his tenure, the Thalassemia Clinical Network, the Blood and Marrow Transplant Clinic
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Society of Hematology
5-Dec-2003


Page: 1 2

Related biology news :

1. DFG presents the 2004 MAK and BAT value lists
2. VIB presents its annual results at BIO2004 in San Francisco
3. Steroid-coated DNA represents new approach to gene delivery
4. DFG presents the new MAK and BAT Value List 2003
5. Center for Health Law and Policy presents program on bioterrorism measures and civil liberties
6. Agriculture presents common ground for rural, urban people
7. UPCI presents study on estrogenic activity of medicinal botanicals
8. UPCI presents study on dendritic cells in prostate cancer
9. UPCI presents study on discovery of protein that suppresses dendritic cells
10. USF presents new research on hyperlipidemic children
11. Biomedicines presents promising results from phase II trials of omega interferon for the treatment of hepatitis C

Post Your Comments:
(Date:5/19/2013)... that can grow using hydrogen gas as its sole ... of carbon. Researchers at the University of Massachusetts, ... of the American Society for Microbiology. , "This represents ... says Amit Kumar, a researcher on the study who, ... Lab Group at the university. , Under the leadership ...
(Date:5/18/2013)... 18, 2013) An increasing number of U.S. ... to resolve, according to research presented at Digestive ... targeting obesity, researchers at the Cleveland Clinic Children,s ... pattern of exhaled breath compared to their lean ... compound levels that can be correlated to potential ...
(Date:5/17/2013)... of proteins in the brain responsible for protecting nerve ... could increase cell survival. , The discovery, made by ... in the EMBO journal with additional comment ... for stroke and other brain diseases. , The research ... a protein, known as SUMO, responsible for controlling the ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3SUMO wrestling cells reveal new protective mechanism target for stroke 2
(Date:5/17/2013)... 2013 New interactive learning ... thought leaders of the medical device industry at ... and expo, from June 18-20 in ... http://photos.prnewswire.com/prnh/20130517/613829 ) , These all-new ... professionals practical presentations and implementable solutions on the ...
(Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. (NASDAQ: ... leading developer, manufacturer, and distributor of crop nutrient products ... , today announced that, on May 16, 2013, the ... directors (the "Board of Directors") was provided a letter ... Hong Kong ) Limited ("Abax") to Full Alliance ...
(Date:5/17/2013)... -- Insero Health, Inc., a company developing natural compounds to ... disorders, is today reporting top-line results from a Phase ... with drug-resistant epilepsy.  The data are being presented at ... by Dr. Steven Schachter , Harvard ... Board.  In this study, INS001 appeared safe and well ...
(Date:5/17/2013)... Canada (PRWEB) May 17, 2013 The ... understanding complex biological systems that can help predict the ... speaker Dr. Sergey Stepaniants, Head of Computational Biology at ... computational biology tools to ensure high-quality genomics when used ... can be applied to complex data sets to identify ...
Breaking Biology Technology:MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
Cached News: